Precocious Puberty: Understanding Causes, Symptoms & Prevalence

Precocious puberty (PP) = secondary sexual characteristics before age 8 in girls, 9 in boys. Incidence: 1:5,000–1:10,000; female:male ratio ~4:1.

Types

  • Central (GnRH-dependent): premature HPG axis activation; idiopathic (90% girls), CNS lesions (tumors, hamartoma, post-radiation).
  • Peripheral (GnRH-independent): autonomous sex steroid production (ovarian/testicular tumors, adrenal hyperplasia, exogenous hormones).

Trends

Secular decline in pubertal onset age over past decades; possible contributors: increased BMI, endocrine disruptors, psychosocial stress. True PP prevalence rising; requires distinction from benign variants (premature thelarche, adrenarche).

Evaluation

  • Bone age (advanced).
  • Basal/stimulated LH/FSH (GnRH agonist test).
  • Pelvic/Adrenal MRI if central.
  • Genetic testing (MKRN3, DLK1) emerging.

Treatment

GnRH analogs (leuprolide, triptorelin) for central PP: halt progression, preserve adult height, mitigate psychosocial impact.

Genetic Disorders - Related Articles